Donor Natural Killer Cells, Cyclophosphamide, and Etoposide in Treating Children and Young Adults With Relapsed or Refractory Solid Tumors
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
University of Pennsylvania
Canadian Cancer Trials Group
H. Lee Moffitt Cancer Center and Research Institute
Memorial Sloan Kettering Cancer Center
City of Hope Medical Center
University Health Network, Toronto
St. Jude Children's Research Hospital
Allogene Therapeutics
Baylor College of Medicine
Fred Hutchinson Cancer Center
University of California, Davis
Acepodia Biotech, Inc.
Herlev Hospital
AvenCell Therapeutics, Inc.
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
HRYZ Biotech Co.
Fudan University
Leap Therapeutics, Inc.
Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd
Fate Therapeutics
Fate Therapeutics
Fate Therapeutics
Genocea Biosciences, Inc.
Emory University
Massachusetts General Hospital
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
University of Oxford
Alden Cancer Therapy II
National Institutes of Health Clinical Center (CC)
Peking University
Peking University
National Institutes of Health Clinical Center (CC)
Mayo Clinic
Providence Health & Services
Merck Sharp & Dohme LLC
Shenzhen Second People's Hospital
Northwestern University
City of Hope Medical Center
Children's Oncology Group
Eisai Inc.
National Institutes of Health Clinical Center (CC)